Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application

J Cancer Res Clin Oncol. 2019 Sep;145(9):2169-2197. doi: 10.1007/s00432-019-02997-x. Epub 2019 Aug 10.

Abstract

Background: Recent studies have shown that the short-chain fatty acids (SCFAs) produced by the gut microbiota play a positive role in the development of colorectal cancer (CRC).

Aims: This study aims to elucidate the "food-microorganism-SCFAs" axis and to provide guidance for prevention and intervention in CRC.

Methods: The PubMed, Embase and Cochrane databases were searched from their inceptions to August 2018, and 75 articles and 25 conference abstracts were included and analysed after identification and screening.

Results: The concentrations of SCFAs in CRC patients and individuals with a high risk of CRC were higher than those in healthy individuals. The protective mechanism of SCFAs against CRC has been described in three aspects: epigenetics, immunology and molecular signalling pathways. Many food and plant extracts that were fermented by microorganisms produced SCFAs that play positive roles with preventive and therapeutic effects on CRC. The "food-microorganism-SCFAs" axis was constructed by summarizing the pertinent literature.

Conclusions: This study provides insight into the basic research and practical application of SCFAs by assessing the protective effect of SCFAs on CRC.

Keywords: Butyrate; Colorectal cancer; Diet; Histone deacetylase; Microorganism; Short-chain fatty acids.

Publication types

  • Systematic Review

MeSH terms

  • Biomedical Research / methods
  • Biomedical Research / trends
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / etiology
  • Colorectal Neoplasms / microbiology
  • Colorectal Neoplasms / prevention & control*
  • Fatty Acids, Volatile / physiology*
  • Fatty Acids, Volatile / therapeutic use
  • Feeding Behavior / physiology*
  • Food
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Practice Patterns, Physicians' / trends
  • Probiotics / therapeutic use
  • Risk Factors
  • Signal Transduction / physiology

Substances

  • Fatty Acids, Volatile